A novel e8a2 BCR-ABL1 intronic fusion through insertion of a chromosome 22 BCR gene fragment into chromosome 9 in an atypical Philadelphia (Ph) chromosome chronic myeloid leukemia patient

Chen Lifeng; Wu Yaohui; You Yong; Xiao Min; Yao Ye; Li Weiming

首页> 外文期刊>Leukemia and lymphoma >A novel e8a2 BCR-ABL1 intronic fusion through insertion of a chromosome 22 BCR gene fragment into chromosome 9 in an atypical Philadelphia (Ph) chromosome chronic myeloid leukemia patient

【24h】

A novel e8a2 BCR-ABL1 intronic fusion through insertion of a chromosome 22 BCR gene fragment into chromosome 9 in an atypical Philadelphia (Ph) chromosome chronic myeloid leukemia patient

机译：一种新型e8a2 BCR-ABL1内含子融合，方法是将非典型费城（Ph）染色体慢性髓性白血病患者的22号BCR基因片段插入9号染色体

获取原文

获取原文并翻译 | 示例

掌桥外文数据库（机构版） >>

开具论文收录证明 >>

文献代查 >>

页面导航

著录项
相似文献
相关主题

著录项

来源
《Leukemia and lymphoma》 |2016年第12期|共4页
作者
Chen Lifeng; Wu Yaohui; You Yong; Xiao Min; Yao Ye; Li Weiming;
展开▼
作者单位

展开▼
收录信息
原文格式 PDF
正文语种 eng
中图分类肿瘤学;
关键词

相似文献

外文文献
中文文献
专利

1. A novel e8a2 BCR-ABL1 intronic fusion through insertion of a chromosome 22 BCR gene fragment into chromosome 9 in an atypical Philadelphia (Ph) chromosome chronic myeloid leukemia patient [J] . Chen Lifeng, Wu Yaohui, You Yong, Leukemia and lymphoma . 2016,第12期

机译：一种新型e8a2 BCR-ABL1内含子融合，方法是将非典型费城（Ph）染色体慢性髓性白血病患者的22号BCR基因片段插入9号染色体
2. Generation of the BCR/ABL fusion gene in a Philadelphia chromosome-negative chronic myeloid leukaemia: insertion of 5.6 Mb of 9q34 into the BCR region of chromosome 22. [J] . Valle L, Fernandez V, Perez Pons C, Hematological oncology . 2006,第2期

机译：费城染色体阴性慢性髓性白血病中BCR / ABL融合基因的产生：将5.6 Mb的9q34插入22号染色体的BCR区域。
3. Aberrant BCR-ABL transcript with intronic insertion in a patient with philadelphia chromosome-positive chronic myeloid leukemia: implications for disease progression. [J] . Shiratsuchi M, Muta K, Minami R, Leukemia and lymphoma . 2001,第3a4期

机译：费城染色体阳性慢性粒细胞白血病患者中内含子插入的异常BCR-ABL转录本：对疾病进展的影响。
4. Novel Inhibitors of T315I Mutant BCR-ABL1 Tyrosine Kinase for Chronic Myeloid Leukemia Disease Through Fragment-Based Drug Design [C] . Satya Anindita, Atika Marnolia, Hersal Hermana Putra, International symposium on bioinformatics research and applications . 2018

机译：T315I突变BCR-ABL1酪氨酸激酶的新型抑制剂通过基于片段的药物设计治疗慢性粒细胞白血病
5. From the Philadelphia chromosome to the cytoskeleton: The role of BCR-ABL in modulating cell adhesion and initiating leukemia. [D] . Wertheim, Jason Albert. 2002

机译：从费城染色体到细胞骨架：BCR-ABL在调节细胞黏附和引发白血病中的作用。
6. Patan hospital experience in treating philadelphia chromosome/BCR-ABL1 positive chronic myeloid leukemia patients with gleevec (imatinib mesylate); the first generation specific tyrosine kinase inhibitor [O] . Gyan K Kayastha, Padma Gurung, Paras K Acharya, 2010

机译：帕坦医院治疗格列卫（甲磺酸伊马替尼）治疗费城染色体/ BCR-ABL1阳性慢性髓性白血病患者的经验；第一代特异性酪氨酸激酶抑制剂
7. Patan hospital experience in treating philadelphia chromosome/BCR-ABL1 positive chronic myeloid leukemia patients with gleevec (imatinib mesylate); the first generation specific tyrosine kinase inhibitor [O] . Zimmerman Mark, Hayes Bruce, Paudyal Buddhi P, 2010

机译：帕坦医院治疗格列卫（甲磺酸伊马替尼）治疗费城染色体/ BCR-ABL1阳性慢性髓性白血病患者的经验；第一代特异性酪氨酸激酶抑制剂
8. Systematic Reviews on Selected Pharmacogenetic Tests for Cancer Treatment: CYP2D6 for Tamoxifen in Breast Cancer, KRAS for anti-EGFR antibodies in Colorectal Cancer, and BCR-ABL1 for Tyrosine Kinase Inhibitors in Chronic Myeloid Leukemia. Technology Assessment Report [R] . Terasawa, T., Dahabreh, I., Castaldi, P. J., 2010

机译：针对癌症治疗的选定药物遗传学测试的系统评价：CYp2D6用于乳腺癌中的他莫昔芬，KRas用于结肠直肠癌中的抗EGFR抗体，以及BCR-aBL1用于慢性髓性白血病中的酪氨酸激酶抑制剂。技术评估报告

A novel e8a2 BCR-ABL1 intronic fusion through insertion of a chromosome 22 BCR gene fragment into chromosome 9 in an atypical Philadelphia (Ph) chromosome chronic myeloid leukemia patient

著录项

相似文献

相关主题

期刊订阅